BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3329111)

  • 1. Double-blind, parallel clinical trial of tenoxicam (Ro 12-0068) versus piroxicam in patients with ankylosing spondylitis.
    Astorga G
    Eur J Rheumatol Inflamm; 1987; 9(2):70-3. PubMed ID: 3329111
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenoxicam (Ro 12-0068) in ankylosing spondylitis.
    Romberg O
    Eur J Rheumatol Inflamm; 1987; 9(2):122-5. PubMed ID: 3329103
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of tenoxicam in osteoarthrosis, rheumatoid arthritis and ankylosing spondylitis.
    Standel W; Josenhants G
    Eur J Rheumatol Inflamm; 1985; 8(1):28-38. PubMed ID: 3915885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind study of tenoxicam 20 mg versus piroxicam 20 mg in rheumatoid arthritis.
    Havranek H
    Eur J Rheumatol Inflamm; 1987; 9(2):105-8. PubMed ID: 3329099
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical, double-blind long-term study of tenoxicam 20 mg (Ro 12-0068) versus piroxicam 20 mg in patients with gonarthrosis.
    Battagliotti CA; Baetti EA
    Eur J Rheumatol Inflamm; 1987; 9(2):74-6. PubMed ID: 3329112
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term, double-blind, comparative study of tenoxicam (Ro 12-0068) and piroxicam in gonarthrosis and coxarthrosis.
    Orozco-Alcalá JJ; Barrera-Tenorio EF
    Eur J Rheumatol Inflamm; 1987; 9(2):109-13. PubMed ID: 3329100
    [No Abstract]   [Full Text] [Related]  

  • 8. Tenoxicam (Ro 12-0068) in patients with extra-articular rheumatism.
    Orozco-Alcalá JJ; Barrera-Tenorio EF
    Eur J Rheumatol Inflamm; 1987; 9(2):114-7. PubMed ID: 3329101
    [No Abstract]   [Full Text] [Related]  

  • 9. Tenoxicam compared with diclofenac in patients with ankylosing spondylitis.
    Schwarzer AC; Cohen M; Arnold MH; Kelly D; McNaught P; Brooks PM
    Curr Med Res Opin; 1990; 11(10):648-53. PubMed ID: 2178870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
    Bird HA; Hill J; Dixon JS; Looi D; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):53-9. PubMed ID: 3915888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis.
    Villa Alcázar LF; de Buergo M; Rico Lenza H; Montull Fruitós E
    J Rheumatol; 1996 Jul; 23(7):1194-9. PubMed ID: 8823692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenoxicam, a new non-steroidal anti-inflammatory drug in the prolonged treatment of rheumatoid arthritis.
    Gentiletti AA
    Eur J Rheumatol Inflamm; 1987; 9(2):91-4. PubMed ID: 3329116
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term study with tenoxicam (Ro 12-0068) in the treatment of gonarthrosis and coxarthrosis.
    Rubinstein J; Sidi A
    Eur J Rheumatol Inflamm; 1987; 9(2):126-8. PubMed ID: 3329104
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind parallel study of tenoxicam (20 mg vs. 40 mg) in extra-articular inflammation.
    Tuso L; Jeunet F; Kunovits G; Pasquier M
    Eur J Rheumatol Inflamm; 1987; 9(2):129-32. PubMed ID: 3329105
    [No Abstract]   [Full Text] [Related]  

  • 15. A parallel group comparison of tenoxicam and piroxicam in patients with ankylosing spondylitis.
    Bird HA; Le Gallez P; Astbury C; Looi D; Wright V
    Pharmatherapeutica; 1986; 4(7):457-62. PubMed ID: 3515371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenoxicam or diclofenac in the treatment of gonarthrosis.
    Chahade WH; Marques GC
    Eur J Rheumatol Inflamm; 1987; 9(2):77-80. PubMed ID: 3329113
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Scand J Rheumatol Suppl; 1987; 65():107-12. PubMed ID: 3317800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term randomised trial on tenoxicam and piroxicam in osteoarthritis of the hip or knee: a 24-month interim report focusing on the 12-24 month interval.
    Lund B; Andersen RB; Fossgreen J; Holm P; Jensen EM; Kirchheiner B; Kryger J; Pichard J
    Eur J Rheumatol Inflamm; 1987; 9(2):58-67. PubMed ID: 3329110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoxicam vs ketoprofen in ankylosing spondylitis.
    Doury P; Roux H
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):157S-160S. PubMed ID: 3620275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of naproxen and piroxicam in rheumatoid arthritis and Bechterew's syndrome. A double-blind parallel multicenter study].
    Myklebust G
    Tidsskr Nor Laegeforen; 1986 Jun; 106(17-18):1485-7. PubMed ID: 3532419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.